Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-05-041014
Filing Date
2005-07-19
Accepted
2005-07-19 15:56:44
Documents
2
Period of Report
2005-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - RESTRICTED STOCK GRANT rrd85651.html 4  
1 FORM 4 - RESTRICTED STOCK GRANT rrd85651.xml 4 4172
2 POWER OF ATTORNEY rrd73550_82765.htm EX-99.1 3173
  Complete submission text file 0001181431-05-041014.txt   9020
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O OXIGENE INC 321 ARSENAL STREET WATERTOWN MA 02472
DRISCOLL FREDERICK W (Reporting) CIK: 0001129890 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 05961695